Matrix metalloproteinases in peripheral vascular disease

被引:115
作者
Hobeika, Mark J.
Thompson, Robert W.
Muhs, Bart E.
Brooks, Peter C.
Gagne, Paul J.
机构
[1] NYU, Sch Med, Dept Surg, New York, NY USA
[2] NYU, Sch Med, Dept Radiat Oncol & Cell Biol, New York, NY USA
[3] Washington Univ, Dept Surg, Sch Med, St Louis, MO 63130 USA
关键词
D O I
10.1016/j.jvs.2006.09.066
中图分类号
R61 [外科手术学];
学科分类号
摘要
Matrix metalloproteinases (MMPs) are extracellular matrix-modifying enzymes that are important in many physiologic and pathologic vascular processes. Dysregulation of MMP activity has been associated with common vascular diseases such as atherosclerotic plaque formation, abdominal aortic aneurysms, and critical limb ischemia. For this reason, MMPs have become an important focus for basic science studies and clinical investigations by vascular biology researchers. This article reviews the recent literature, summarizing our current understanding of the role of Amps in the pathogenesis of various peripheral vascular disease states. In addition, the importance of MMPs in the future diagnosis and treatment of peripheral vascular disease is discussed.
引用
收藏
页码:849 / 857
页数:9
相关论文
共 100 条
[1]   Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model [J].
Allaire, E ;
Forough, R ;
Clowes, W ;
Starcher, B ;
Clowes, AW .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1413-1420
[2]   Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis [J].
Alvarez, B ;
Ruiz, C ;
Chacón, P ;
Alvarez-Sabin, J ;
Matas, M .
JOURNAL OF VASCULAR SURGERY, 2004, 40 (03) :469-475
[3]   Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome [J].
Apple, FS ;
Wu, AHB ;
Mair, J ;
Ravkilde, J ;
Panteghini, M ;
Tate, J ;
Pagani, F ;
Christenson, RH ;
Mockel, M ;
Danne, O ;
Jaffe, AS .
CLINICAL CHEMISTRY, 2005, 51 (05) :810-824
[4]  
Araujo Cristiana Marques de, 2005, Arq Bras Cardiol, V84, P256
[5]   Localized administration of doxycycline suppresses aortic dilatation in an experimental mouse model of abdominal aortic aneurysm [J].
Bartoli, MA ;
Parodi, FE ;
Chu, J ;
Pagano, MB ;
Mao, DL ;
Baxter, BT ;
Buckley, C ;
Ennis, TL ;
Thompson, RW .
ANNALS OF VASCULAR SURGERY, 2006, 20 (02) :228-236
[6]   Could medical intervention work for aortic aneurysms? [J].
Baxter, BT .
AMERICAN JOURNAL OF SURGERY, 2004, 188 (06) :628-632
[7]   Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: Report of a prospective (Phase II) multicenter study [J].
Baxter, BT ;
Pearce, WH ;
Waltke, EA ;
Littooy, FN ;
Hallett, JW ;
Kent, KC ;
Upchurch, GR ;
Chaikof, EL ;
Mills, JL ;
Fleckten, B ;
Longo, GM ;
Lee, JK ;
Thompson, RW .
JOURNAL OF VASCULAR SURGERY, 2002, 36 (01) :1-12
[8]   HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages [J].
Bellosta, S ;
Via, D ;
Canavesi, M ;
Pfister, P ;
Fumagalli, R ;
Paoletti, R ;
Bernini, F .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (11) :1671-1678
[9]   Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury [J].
Bendeck, MP ;
Conte, M ;
Zhang, MY ;
Nili, N ;
Strauss, BH ;
Farwell, SM .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (03) :1089-1095
[10]   IDENTIFICATION OF 92-KD GELATINASE IN HUMAN CORONARY ATHEROSCLEROTIC LESIONS - ASSOCIATION OF ACTIVE ENZYME-SYNTHESIS WITH UNSTABLE ANGINA [J].
BROWN, DL ;
HIBBS, MS ;
KEARNEY, M ;
LOUSHIN, C ;
ISNER, JM .
CIRCULATION, 1995, 91 (08) :2125-2131